Compare FTAI Aviation Ltd (FTAI) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FTAI Aviation Ltd vs Immunovant Inc. Common Stock — how do they compare? FTAI Aviation Ltd trades at $171 (market cap $17.96B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: FTAI Aviation Ltd is far larger — about 2.7× Immunovant Inc. Common Stock's market cap, and FTAI Aviation Ltd pays a 1.14% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold FTAI Aviation Ltd for 22 Days and Immunovant Inc. Common Stock for 0 Days on average.
| FTAI | IMVT | |
|---|---|---|
Market Cap | $17.96B | $6.62B |
Volume | 1,695,650 | 1,131,364 |
Sector | Industrials | Health |
52-Week High | $310.04 | $44.96 |
52-Week Low | $152.80 | $17.03 |
Typical Hold Time | 22 Days | 0 Days |
Enterprise Value | $21.07B | $5.72B |
Dividend Yield | 1.14% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FTAI Aviation trades at $174.83, down 2.57% today, with a bearish technical signal. The company reported strong revenue growth to $2.51B in 2025 but missed EPS estimates for three consecutive quarters. Recent developments include a $500 million share repurchase program and a strategic acquisition of 27 Boeing aircraft, signaling aggressive expansion. Analyst consensus remains unanimously bullish with a $321.25 price target, despite negative operating cash flow and declining net income margins.
The outlook is mixed: robust institutional support and growth initiatives contrast with earnings misses and cash flow concerns. Key risks include execution of new ventures and sensitivity to aviation sector cycles. The stock offers significant upside if operational improvements materialize, but investors face volatility from quarterly performance gaps and macroeconomic pressures on the industry.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FTAI Aviation Ltd
FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
